Works matching IS 00071188 AND DT 2020 AND VI 177 AND IP 21
Results: 19
Proteinase‐activated receptor 1: A target for repurposing in the treatment of COVID‐19?
- Published in:
- British Journal of Pharmacology, 2020, v. 177, n. 21, p. 4971, doi. 10.1111/bph.15194
- By:
- Publication type:
- Article
Novel approach for low‐dose pulmonary delivery of hydroxychloroquine in COVID‐19.
- Published in:
- British Journal of Pharmacology, 2020, v. 177, n. 21, p. 4997, doi. 10.1111/bph.15167
- By:
- Publication type:
- Article
Statins: Could an old friend help in the fight against COVID‐19?
- Published in:
- British Journal of Pharmacology, 2020, v. 177, n. 21, p. 4873, doi. 10.1111/bph.15166
- By:
- Publication type:
- Article
The potential of cannabidiol in the COVID‐19 pandemic.
- Published in:
- British Journal of Pharmacology, 2020, v. 177, n. 21, p. 4967, doi. 10.1111/bph.15157
- By:
- Publication type:
- Article
A lesson from a saboteur: High‐MW kininogen impact in coronavirus‐induced disease 2019.
- Published in:
- British Journal of Pharmacology, 2020, v. 177, n. 21, p. 4866, doi. 10.1111/bph.15154
- By:
- Publication type:
- Article
Databases for the targeted COVID-19 therapeutics.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Anti‐inflammatory and antiviral roles of hydrogen sulfide: Rationale for considering H<sub>2</sub>S donors in COVID‐19 therapy.
- Published in:
- British Journal of Pharmacology, 2020, v. 177, n. 21, p. 4931, doi. 10.1111/bph.15230
- By:
- Publication type:
- Article
The hidden role of NLRP3 inflammasome in obesity‐related COVID‐19 exacerbations: Lessons for drug repurposing.
- Published in:
- British Journal of Pharmacology, 2020, v. 177, n. 21, p. 4921, doi. 10.1111/bph.15229
- By:
- Publication type:
- Article
Non‐steroidal anti‐inflammatory drugs, prostaglandins, and COVID‐19.
- Published in:
- British Journal of Pharmacology, 2020, v. 177, n. 21, p. 4899, doi. 10.1111/bph.15206
- By:
- Publication type:
- Article
Targeting zinc metalloenzymes in coronavirus disease 2019.
- Published in:
- British Journal of Pharmacology, 2020, v. 177, n. 21, p. 4887, doi. 10.1111/bph.15199
- By:
- Publication type:
- Article
Animal models of mechanisms of SARS‐CoV‐2 infection and COVID‐19 pathology.
- Published in:
- British Journal of Pharmacology, 2020, v. 177, n. 21, p. 4851, doi. 10.1111/bph.15143
- By:
- Publication type:
- Article
The case for chronotherapy in Covid‐19‐induced acute respiratory distress syndrome.
- Published in:
- British Journal of Pharmacology, 2020, v. 177, n. 21, p. 4845, doi. 10.1111/bph.15140
- By:
- Publication type:
- Article
A rationale for targeting the P2X7 receptor in Coronavirus disease 19.
- Published in:
- British Journal of Pharmacology, 2020, v. 177, n. 21, p. 4990, doi. 10.1111/bph.15138
- By:
- Publication type:
- Article
Lung tissue distribution of drugs as a key factor for COVID-19 treatment.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Acute chloroquine poisoning: A comprehensive experimental toxicology assessment of the role of diazepam.
- Published in:
- British Journal of Pharmacology, 2020, v. 177, n. 21, p. 4975, doi. 10.1111/bph.15101
- By:
- Publication type:
- Article
A hypothesis for pathobiology and treatment of COVID-19: The centrality of ACE1/ACE2 imbalance.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Current pharmacological treatments for COVID-19: What's next?
- Published in:
- 2020
- By:
- Publication type:
- journal article
Issue Information.
- Published in:
- British Journal of Pharmacology, 2020, v. 177, n. 21, p. 4811, doi. 10.1111/bph.14740
- Publication type:
- Article
A rational roadmap for SARS‐CoV‐2/COVID‐19 pharmacotherapeutic research and development: IUPHAR Review 29.
- Published in:
- British Journal of Pharmacology, 2020, v. 177, n. 21, p. 4942, doi. 10.1111/bph.15094
- By:
- Publication type:
- Article